SABS
#3364
SAB Biotherapeutics, Inc. - Common Stock
2.6 6 USD
-0.06%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-6.01%
Variación mensual
-22.22%
Variación en los últimos 6 meses
-32.66%
Cambio anual
+16.16%
Cierres anteriores
2.8 3
Open
2.8 4
Mínimo
2.6 6
Máximo
2.8 8
Financials
- Market Capitalization 242.02 M
- Employee 86
- Founded 2014
- CEO N/A
- Website www.sab.bio
- Headquarter Delaware, United States
- FIGI BBG00YHY0G24
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.73
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3341 |  ABEO Abeona Therapeutics Inc. - Common Stock | 4.59 USD | -6.33% | -8.38% | -15.16% | -13.88% | 262.47 M USD | ||
| 3353 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 2.03 USD | -6.45% | +10.93% | +100.99% | +123.08% | 258.33 M USD | ||
| 3371 |  RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 2.26 USD | -8.87% | -9.24% | -31.31% | -42.35% | 248.09 M USD | ||
| 3373 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 1.80 USD | -2.70% | -9.55% | -23.08% | +13.92% | 251.16 M USD |